Aerosol droplet formation during HFNC treatment * risk assessment for SARS-CoV-2 transmission to health care workers

Aerosol droplet formation during HFNC treatment * risk assessment for SARS-CoV-2 transmission to health care workers - Aerosol droplets during HFNC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49784

Enrollment

Registered

2020-05-13

Start date

2020-05-18

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 hypoxemia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers

Exclusion criteria

Exclusion criteria: Chronic respiratory diseases, fever or upper respiratory disease symptoms in the last 2 weeks prior to participation

Design outcomes

Primary

Measure	Time frame
Aerosol droplet formation (quantification per surface area) and travel velocity.	—

Countries

Netherlands

Outcome results